Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harris Nesbitt Gerard was a U.S.-based investment banking and institutional brokerage firm that operated as the investment banking arm of BMO Financial Group. The firm was established in 2003 following BMO's acquisition of Gerard Klauer Mattison, a boutique brokerage firm renowned for its research-driven approach. Harris Nesbitt Gerard provided a comprehensive suite of services, including equity research, corporate finance, and sales and trading, with a specialized focus on the healthcare, technology, and consumer sectors. The firm was particularly well-regarded for its healthcare practice and hosted an annual healthcare conference that became a significant event for biotechnology and life sciences companies. In 2006, the entity was rebranded as BMO Capital Markets as part of a global integration of BMO's investment and corporate banking groups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harris Nesbitt Gerard.